CD1 expression in human atherosclerosis: A potential mechanism for T cell activation by foam cells

American Journal of Pathology

Volumn 155, Issue 3, 1999, Pages 775-786

  Melián, Agustín ^a   Geng, Yong Jian ^b   Sukhova, Galina K ^a   Libby, Peter ^a   Porcelli, Steven A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; LOW DENSITY LIPOPROTEIN;

ANTIGEN EXPRESSION; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; FOAM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0032887983     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65176-0     Document Type: Article

References (68)

1. Murray CJ, Lopez AD: Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997, 349:1269-1276
2. Hansson GK, Jonasson L, Seifert PS, Stemme S: Immune mechanisms in atherosclerosis. Arteriosclerosis 1989, 9:567-578
3. Libby P, Hansson GK: Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest 1991, 64:5-15
4. Xu QB, Oberhuber G, Gruschwitz M, Wick G: Immunology of atherosclerosis: cellular composition and major histocompatibility complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens. Clin Immunol Immunopathol 1990, 56:344-359
5. Emeson EE, Robertson AL, Jr: T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis. Am J Pathol 1988, 130:369-376
6. Hansson GK, Jonasson L, Lojsthed B, Stemme S, Kocher O, Gabbiani G: Localization of T lymphocytes and macrophages in fibrous and complicated human atherosclerotic plaques. Atherosclerosis 1988, 72:135-141
7. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809
8. Thomson JG: Production of severe atherosclerosis in a transplanted human heart. Lancet 1969, 2:1088-1092
9. Schroeder JS, Hunt SA: Cardiac transplantation: where are we? N Engl J Med 1986, 315:961-963
10. Griepp RB, Stinson EB, Bieber CP, Reitz BA, Copeland JG, Oyer PE, Shumway NE: Control of graft arteriosclerosis in human heart transplant recipients. Surgery 1977, 81:262-269
11. Taylor DO, Ibrahim HM, Tolman DR, Hess ML: Accelerated coronary atherosclerosis in cardiac transplantation. Transplant Rev 1991, 5:165-174
12. Libby P, Salomon RN, Payne DD, Schoen FJ, Pober JS: Functions of vascular wall cells related to development of transplantation-associated coronary arteriosclerosis. Transplant Proc 1989, 21:3677-3684
13. Koulack J, McAlister VC, MacAulay MA, Bitter-Suermann H, MacDonald AS, Lee TD: Importance of minor histocompatibility antigens in the development of allograft arteriosclerosis. Clin Immunol Immunopathol 1996, 80:273-277
14. Dansky HM, Charlton SA, Harper MM, Smith JD: T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci USA 1997, 94:4642-4646
15. Emeson EE, Shen ML, Bell CG, Qureshi A: Inhibition of atherosclerosis in CD4 T-cell-ablated and nude (nu/nu) C57BL/6 hyperlipidemic mice. Am J Pathol 1996, 149:675-685
16. Mach F, Schonbeck U, Sukhova GK, Atkinson E, Libby P: Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 1998, 394:200-203
17. Gupta S, Pablo AM, Jiang X, Wang N, Tall AR, Schindler C: IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest 1997, 99:2752-2761
18. Jonasson L, Holm J, Skalli O, Gabbiani G, Hansson GK: Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J Clin Invest 1985, 76:125-131
19. van der Wal AC, Das PK, Bentz van de Berg D, van der Loos CM, Becker AE: Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest 1989, 61:166-170
20. Wick G, Kleindienst R. Schett G, Amberger A, Xu O: Role of heat shock protein 65/60 in the pathogenesis of atherosclerosis. Int Arch Allergy Immunol 1995, 107:130-131
21. Wick G, Schett G, Amberger A, Kleindienst R, Xu Q: Is atherosclerosis an immunologically mediated disease? Immunol Today 1995, 16: 27-33
22. Xu Q, Dietrich H, Steiner HJ, Gown AM, Shoel B, Mikuz G, Kaufman SH, Wick G: Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb 1992, 12:789-799.
23. Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK: T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA 1995, 92:3893-3897
24. Adam E, Melnick JL, Probtsfield JL, Petrie BL, Burek J, Bailey KR, McCollum CH, DeBakey ME: High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 1987, 2:291-293
25. Benditt EP, Barrett T, McDougall JK: Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci USA 1983, 80:6386-6389
26. Thom DH, Wang SP, Grayston JT, Siscovick DS, Stewart DK, Kronmal RA, Weiss NS: Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb 1991, 11:547-551
27. Porcelli SA: The CD1 family: a third lineage of antigen-presenting molecules. Adv Immunol 1995, 59:1-98
28. Melian A, Beckman EM, Porcelli SA, Brenner MB: Antigen presentation by CD1 and MHC-encoded class I-like molecules. Curr Opin Immunol 1996, 8:82-88
29. Porcelli SA, Segelke BW, Sugita M, Wilson IA, Brenner MB: The CD1 family of lipid antigen-presenting molecules. Immunol Today 1998, 19:362-368
30. Beckman EM, Porcelli SA, Morita CT, Behar SM, Furlong ST, Brenner MB: Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. Nature 1994, 372:691-694
31. Sieling PA, Chatterjee D, Porcelli SA, Prigozy TI, Mazzacaro RJ, Soriano T, Bloom BR, Brenner MB, Kronnenberg M, Brennan PJ, Modlin RL: CD1-restricted T cell recognition of microbial lipoglycan antigens (see comments). Science 1995, 269:227-230
32. Moody DB, Reinhold BB, Guy MR, Beckman EM, Frederique DE, Furlong ST, Ye S, Reinhold VN, Sieling PA, Modlin RL, Besra GS, Porcelli SA: Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science 1997, 278:283-286
33. Beckman EM, Melian A, Behar SM, Sieling PA, Chatterjee D, Furlong ST, Matsumoto R, Rosat JP, Modlin RL, Porcelli SA: CD1c restricts responses of mycobacteria-specific T cells: evidence for antigen presentation by a second member of the human CD1 family. J Immunol 1996, 157:2795-2803
34. Bendelac A, Lantz O, Quimby ME, Yewdell JW, Bennink JR, Brutkiewicz RR: CD1 recognition by mouse NK1+ T lymphocytes. Science 1995, 268:863-865
35. Cardell S, Tangri S, Chan S, Kronenberg M, Benoist C, Mathis D: CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice. J Exp Med 1995, 182:993-1004
36. Porcelli S, Brenner MB, Greenstein JL, Balk SP, Terhorst C, Bleicher PA: Recognition of cluster of differentiation 1 antigens by human CD4-CD8-cytolytic T lymphocytes. Nature 1989, 341:447-450
37. Schofield L, McConville MJ, Hansen D, Campell AS, Fraser-Reid B, Grusby MJ, Tachado SD: CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 1999, 283:225-229
38. Joyce S, Woods AS, Yewdell JW, Bennink JR, DeSilva AD, Boesteanu A, Balk SP, Cotter RJ, Brutkiewicz RR: Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science 1998, 279: 1541-1544
39. Behar SM, Porcelli SA, Beckman EM, Brenner MB: A pathway of costimulation that prevents anergy in CD28-T cells: B7-independent costimulation of CD1-restricted T cells. J Exp Med 1995, 182:2007-2018
40. Exley M, Garcia J, Balk SP, Porcelli S: Requirements for CD1d recognition by human invariant V α24+ CD4-CD8-T cells. J Exp Med 1997, 186:109-120
41. Olive D, Dubreuil P, Mawas C: Two distinct TL-like molecular subsets defined by monoclonal antibodies on the surface of human thymocytes with different expression on leukemia lines. Immunogenetics 1984, 20:253-264
42. Boumsell L: Leukocyte Typing IV. Edited by Knapp W. Oxford, Oxford University Press, 1989, pp 251-254
43. Brodsky FM, Parham P: Monomorphic anti-HLA-A,B,C monoclonal antibodies detecting molecular subunits and combinatorial determinants. J Immunol 1982, 128:129-135
44. Lampson LA, Levy R: Two populations of Ia-like molecules on a human B cell line. J Immunol 1980, 125:293-299
45. Van Voorhis WC, Steinman RM, Hair LS, Luban J, Witmer MD, Koide S, Cohn ZA: Specific antimononuclear phagocyte antibodies: application to the purification of dendritic cells and the tissue localization of macrophages. J Exp Med 1983, 158:126-145
46. de Fougerolles AR, Springer TA: Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes. J Exp Med 1992, 175:185-190
47. Miller LJ, Schwarting R, Springer TA: Regulated expression of the Mac-1. LFA-1, p150,95 glycoprotein family during leukocyte differentiation. J Immunol 1986, 137:2891-2900
48. Changelian PS, Fearon DT: Tissue-specific phosphorylation of complement receptors CR1 and CR2. J Exp Med 1986, 163:101-115
49. Panchamoorthy G, McLean J, Modlin RL, Morita CT, Ishiwaka S, Brenner MB, Band H: A predominance of the T cell receptor V γ 2/V Δ2 subset in human mycobacteria-responsive T cells suggests germ-line gene encoded recognition. J Immunol 1991, 147:3360-3369
50. Stenger S, Mazzacaro RJ, Uyemura K, Cho S, Barnes PF, Rosat JP, Sette A, Brenner MB, Porcelli SA, Bloom BR, Modlin RL: Differential effects of cytolytic T cell subsets on intracellular infection. Science 1997, 276:1684-1687
51. Porcelli S, Morita CT, Brenner MB: CD1b restricts the response of human CD4-8-T lymphocytes to a microbial antigen. Nature 1992, 360:593-597
52. Rosat JP, Grant EP, Beckman EM, Dascher CC, Sieling PA. Frederique D, Modlin RL, Porcelli SA, Furlong ST, Brenner MB: CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool. J Immunol 1999, 162:366-371
53. Anegon I, Grolleau D, Soulillou JP: Regulation of HILDA/LIF gene expression in activated human monocytic cells. J Immunol 1991, 147:3973-3980
54. Greenspan P, Mayer EP, Fowler SD: Nile red: a selective fluorescent stain for intracellular lipid droplets. J Cell Biol 1985, 100:965-973
55. Poston RN, Hussain IF: The immunohistochemical heterogeneity of atheroma macrophages: comparison with lymphoid tissues suggests that recently blood-derived macrophages can be distinguished from longer-resident cells. J Histochem Cytochem 1993, 41:1503-1512
56. Seifert PS, Hansson GK: Complement receptors and regulatory proteins in human atherosclerotic lesions. Arteriosclerosis 1989, 9:802-811
57. Saito E, Fujioka T, Kanno H, Hata E, Ueno T, Matsumoto T, Takahashi Y, Tochihora T, Yasugi T: Complement receptors in atherosclerotic lesions. Artery 1992, 19:47-62
58. Mehrabian M, Demer LL, Lusis AJ: Differential accumulation of intimal monocyte-macrophages relative to lipoproteins and lipofuscin corresponds to hemodynamic forces on cardiac valves in mice. Arterioscler Thromb 1991, 11:947-957
59. Brossay L, Jullien D, Cardell S, Sydova BC, Burdin N, Modlin RL, Kronneberg M: Mouse CD1 is mainly expressed on hemopoietic-derived cells. J Immunol 1997, 159:1216-1224
60. Roark JH, Park SH, Jayawardena J, Kavita U, Shannon M, Bendelac A: CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells. J Immunol 1998, 160:3121-3127
61. Calabi F, Milstein C: A novel family of major histocompatibility complex-related genes not mapping to chromosome 6. Nature 1999, 323:540-543
62. Spada FM, Koezuka Y, Porcelli SA: CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med 1998, 188:1529-1534
63. Zeng Z, Castano AR, Segelke BW, Stura EA, Peterson PA, Wilson IA: Crystal structure of mouse CD1 : an MHC-like fold with a large hydrophobic binding groove. Science 1997, 277:339-345
64. Shamshieu A, Donda A, Carena I, Mori L, DeLibero G: Self glycolipids as T cell autoantigens. Eur J Immunol 1999, 29:1667-1675
65. Stemme S, Holm J, Hansson GK: T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler Thromb 1992, 12:206-211
66. Hansson GK, Holm J, Jonasson L. Detection ot activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 1989, 135: 169-175
67. Rekhter MD, Gordon D: Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques. Am J Pathol 1995, 147:668-677
68. Xu Q, Kleindienst R, Waitz W, Dietrich H, Wick G: Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65. J Clin Invest 1993, 91:2693-2702